Groundbreaking preclinical results A team of researchers from several institutions has reported encouraging preclinical results for a novel compound, tentatively named X-101, that blocks the growth of lung cancer cells. In laboratory experiments, the compound significantly reduced cancer cell proliferation across multiple non-small cell lung cancer (NSCLC) lines and hindered tumor growth in mouse models.…